Patents by Inventor Michael Mark

Michael Mark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Integrated reference pixel
    Patent number: 9635351
    Abstract: Representative implementations of devices and techniques provide dynamic calibration for imaging devices and systems. A reference pixel is arranged to receive an electrical reference signal and to output a calibration signal. The reference signal may be based on imaging illumination.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: April 25, 2017
    Assignee: Infineon Technologies AG
    Inventors: Markus Dielacher, Martin Flatscher, Michael Mark, Josef Prainsack
  • USES OF DPP IV INHIBITORS
    Publication number: 20170087160
    Abstract: The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments.
    Type: Application
    Filed: December 8, 2016
    Publication date: March 30, 2017
    Inventors: Klaus DUGI, Frank HIMMELSBACH, Michael MARK
  • Combination therapy
    Patent number: 9603851
    Abstract: The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: March 28, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Klein, Rolf Grempler, Michael Mark
  • 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    Publication number: 20170081329
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Application
    Filed: December 1, 2016
    Publication date: March 23, 2017
    Inventors: Frank HIMMELSBACH, Elke LANGKOPF, Matthias ECKHARDT, Michael MARK, Roland MAIER, Ralf LOTZ, Mohammad TADAYYON
  • USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME
    Publication number: 20170065595
    Abstract: The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.
    Type: Application
    Filed: November 17, 2016
    Publication date: March 9, 2017
    Inventors: Thomas KLEIN, Maximilian von EYNATTEN, Berthold HOCHER, Michael MARK, Yuliya SHARKOVSKA
  • Connector having a cap with a brace to prevent decoupling of the cap from an engagement member
    Patent number: 9583843
    Abstract: A connector includes a cable tray configured to receive and retain a cable in a stable position and couple with a top cap configured to create an electrical connection with the cable as the top cap is manipulated in a predetermined manner while coupled with the cable tray. An upper surface of the cable tray is configured to receive the cable. The cable tray also includes a finger extending beyond the first end for some distance longitudinally. The finger includes a protrusion that protrudes to some extent in a transverse direction so that a cable-accommodating gap is defined between the protrusion and the first end. The protrusion is configured to bear against the cable and retain the cable in the stable position when the cable is inserted between the protrusion and the first end (before, during and/or after an electrical connection is established).
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: February 28, 2017
    Assignee: LOWE'S COMPANIES, INC.
    Inventors: Jean Tuck McGregor, James Michael Broughman, Allen R. Nelson, Darren Michael Mark, Laura Winfield Alexander, Donald Collins Meves
  • IMAGING APPARATUS AND IMAGING METHOD FOR CAPTURING IMAGING DATA VIA A PIXEL ARRAY
    Publication number: 20170034464
    Abstract: The present disclosure relates to an imaging apparatus. The imaging apparatus comprises a pixel array. The pixel array comprises a first pixel comprising a first radiation-sensitive region and at least one associated charge storage region for collecting electrical charges from the first radiation-sensitive region. The pixel array also comprises a second pixel comprising a second radiation-sensitive region and at least one associated charge storage region for collecting electrical charges from the second radiation-sensitive region. Furthermore, the imaging apparatus comprises control circuitry configured to generate a common compensation signal being common to the first and second pixels. The common compensation signal mitigates a saturation of the respective charge storage regions of the first and second pixels.
    Type: Application
    Filed: June 29, 2016
    Publication date: February 2, 2017
    Inventors: Markus DIELACHER, Martin FLATSCHER, Stefan GANSINGER, Michael MARK, Josef PRAINSACK, Hartwig UNTERASSINGER
  • 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions
    Patent number: 9556175
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: January 31, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Michael Mark, Roland Maier, Ralf Lotz, Mohammad Tadayyon
  • PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20170020907
    Abstract: The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
    Type: Application
    Filed: October 5, 2016
    Publication date: January 26, 2017
    Inventors: Peter EICKELMANN, Michael MARK, Leo John SEMAN, Leo THOMAS, Uli Christian BROEDL, Rolf GREMPLER
  • Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
    Patent number: 9526730
    Abstract: The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: December 27, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Klein, Maximilian von Eynatten, Berthold Hocher, Michael Mark, Yuliya Sharkovska
  • TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN
    Publication number: 20160354380
    Abstract: The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
    Type: Application
    Filed: August 12, 2016
    Publication date: December 8, 2016
    Inventors: Klaus DUGI, Eva Ulrike GRAEFE-MODY, Michael MARK, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING
  • 1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-PIPERIDIN-1-YL]-XANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL
    Publication number: 20160346288
    Abstract: A method of treating a metabolic disorder or metabolic disease includes administering a pharmaceutically effective dose of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine, or a pharmaceutically acceptable salt thereof, to a predominantly carnivorous non-human animal in need thereof such that the severity of one or more clinical symptoms of the metabolic disorder or metabolic disease is reduced.
    Type: Application
    Filed: August 13, 2016
    Publication date: December 1, 2016
    Inventors: Frerich DE VRIES, Dirk HOERSTERMANN, Ingo LANG, Michael MARK, Randolph SEIDLER, Leo THOMAS
  • Photocatalytic teeth whitening
    Patent number: 9492257
    Abstract: The present disclosure relates to devices, methods and kits for accelerating the rate of whitening of teeth using an oxidizing agent, a photocatalytic agent, and a portable lightsource.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: November 15, 2016
    Assignee: Jasibo, LLC
    Inventors: Jennifer Jablow, Michael Mark Muehlemann
  • SYSTEMS AND METHODS FOR TIME OF FLIGHT MEASUREMENT USING A SINGLE EXPOSURE
    Publication number: 20160327638
    Abstract: A sensor array arrangement for a time of flight measurement system is disclosed. The arrangement includes a plurality of pixels and circuitry. The plurality of pixels are configured such that a first plurality of pixels receive a first reference signal and a second plurality of pixels receive a second reference signal. The first and second reference signals are phase shifted with respect to each other. The circuitry calculates depth information by combining information from first and second pixel sensor signals. The first pixel sensor signal is based on the first reference signal. The second pixel sensor signal is based on the second reference signal.
    Type: Application
    Filed: May 4, 2015
    Publication date: November 10, 2016
    Inventors: Markus Dielacher, Josef Prainsack, Martin Flatscher, Michael Mark, Hartwig Unterassinger
  • Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
    Patent number: 9457029
    Abstract: The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
    Type: Grant
    Filed: November 26, 2010
    Date of Patent: October 4, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Dugi, Eva Ulrike Graefe-Mody, Michael Mark, Hans-Juergen Woerle, Heike Zimdahl-Gelling
  • Electric machine housing
    Patent number: 9431881
    Abstract: A housing for enclosing electronics of a motor having an axis of rotation is provided. The housing includes an end cap having an outer surface and an inner surface. A control board is coupled to the inner surface, wherein the printed circuit board includes a first side, a second side and an edge located between the first side and the second side. The housing further includes a first circuit coupled to the first side which includes a plurality of first electrical components. Each first electrical component includes a tab extending beyond the edge. A second circuit is coupled to the second side and a fastener assembly is coupled to the tab and the inner surface.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 30, 2016
    Assignee: REGAL BELOIT AMERICA, INC.
    Inventors: David Allen Clendenen, Michael A. Marks, Peter B. Lytle, Harold Clifton Kingrey, Steven P. Richardville
  • PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES
    Publication number: 20160206620
    Abstract: The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for wound healing preferably in diabetic patients.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 21, 2016
    Inventors: Thomas KLEIN, Michael MARK
  • Connector having a stabilizer in contact with a contact holder or an engagement member of a cable tray
    Patent number: 9391377
    Abstract: A connector includes a cable tray configured to receive and retain a cable in a stable position and couple with a top cap configured to create an electrical connection with the cable as the top cap is manipulated in a predetermined manner while coupled with the cable tray. An upper surface of the cable tray is configured to receive the cable. The cable tray also includes a finger extending beyond the first end for some distance longitudinally. The finger includes a protrusion that protrudes to some extent in a transverse direction so that a cable-accommodating gap is defined between the protrusion and the first end. The protrusion is configured to bear against the cable and retain the cable in the stable position when the cable is inserted between the protrusion and the first end (before, during and/or after an electrical connection is established).
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: July 12, 2016
    Assignee: LOWE'S COMPANIES, INC.
    Inventors: Jean Tuck McGregor, James Michael Broughman, Allen R. Nelson, Darren Michael Mark, Laura Winfield Alexander, Donald Collins Meves
  • 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160194327
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Application
    Filed: March 15, 2016
    Publication date: July 7, 2016
    Inventors: Frank HIMMELSBACH, Elke LANGKOPF, Matthias ECKHARDT, Michael MARK, Roland MAIER, Ralf LOTZ, Mohammad TADAYYON
  • Handle for a vehicle
    Patent number: D772682
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: November 29, 2016
    Assignee: Caterpillar Inc.
    Inventors: Jason Edward Stibs, Michael Eugene Lee, Michael Mark Conrad, Michael Scott Hemry, Gregory James Parsons